Events of reproductive life and the incidence of epithelial ovarian cancer

American Journal of Epidemiology

Volumn 117, Issue 2, 1983, Pages 128-139

  Risch, Harvey A ^a   Weiss, Noel S ^a,b   Lyon, J Lynn ^c   Daling, Janet R ^a,b   Liff, Jonathan M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Anovulation; Ovarian neoplasms; Reproduction; Retrospective studies

Indexed keywords

ABORTION; CONTRACEPTION; ENDOCRINE SYSTEM; FEMALE GENITAL SYSTEM; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; LACTATION; OVARY CARCINOMA; PREGNANCY; REPRODUCTION; RISK FACTOR; SHORT SURVEY; UNITED STATES;

ABORTION, SPONTANEOUS; AMERICAS; BIOLOGY; BODY WEIGHT; CANCER; COMPARATIVE STUDIES; CONTRACEPTION; CONTRACEPTIVE METHODS; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRIES; DISEASES; FAMILY PLANNING; FERTILITY; FERTILITY MEASUREMENTS; GONADOTROPINS; GONADOTROPINS, PITUITARY; INCIDENCE; LACTATION; MATERNAL PHYSIOLOGY; MEASUREMENT; NEOPLASMS; NORTH AMERICA; NORTHERN AMERICA; OBESITY; ORAL CONTRACEPTIVES; OVARIAN CANCER; PARITY; PHYSIOLOGY; POPULATION; POPULATION DYNAMICS; PREGNANCY; PREGNANCY COMPLICATIONS; REPRODUCTION; RESEARCH METHODOLOGY; STUDIES; UNITED STATES; UTAH; WASHINGTON;

ADULT; AGED; ANOVULATION; CONTRACEPTIVES, ORAL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LACTATION; MIDDLE AGED; OVARIAN NEOPLASMS; PARITY; PREGNANCY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; UTAH; WASHINGTON;

EID: 0020698411     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a113523     Document Type: Article

References (47)

1. Weiss NS, Homonchuk T, Young JL. Incidence of the histologic types of ovarian cancer: the U.S. third national cancer survey, 1969-1971. Gynecol Oncol 1977, 5:161-7.
2. Weiss NS, Lyon JL, Krishnamurthy S, et al. Noncontraceptive estrogen use and the occurrence of ovarian cancer. JNCI 1982;68:95-8.
3. Weiss NS, Lyon JL, Liff JM, et al. Incidence of ovarian cancer in relation to the use of oral contraceptives. Int J Cancer 1981;28:669-71.
4. Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1—the analysis of casecontrol studies. Lyon: IARC, 1980.
5. Baker RJ, Nelder JA. The GLIM system. Rel 3. Oxford: Royal Statistical Society, 1978.
6. Metropolitan Life Insurance Co. New weight standards for men and women. Statist Bull Metrop Life Insur Co 1959;40:1-10.
7. Casagrande JT, Pike MC, Ross RK, et al. "Incessant ovulation" and ovarian cancer. Lancet 1979;2:170-3.
8. Fathalla MF. Incessant ovulation—a factor in ovarian neoplasia? Lancet 1971;2:163.
9. Salber EJ, Feinleib M, MacMahon B. The duration of postpartum amenorrhea. Am J Epidemiol 1966:82:347-58.
10. Cronin TJ. Influence of lactation upon ovulation. Lancet 1968;2:422-4.
11. Perez A, Vela P, Masnick GS, et al. First ovulation after childbirth: the effect of breastfeeding. Am J Obstet Gynecol 1972;114:1041-7.
12. Rolland R, Lequin RM, Schellekens LA, et al. The role of prolactin in the restoration of ovarian function during the early post-partum period in the human female: 1. A study during physiological lactation. Clin Endocrinol 1975;4:15-25.
13. Prema K, Naidu AN, Kumari SN. Lactation and fertility. Am J Clin Nutr 1979;32:1298-303.
14. Joly DJ, Lilienfeld AM, Diamond EL, et al. An epidemiologic study of the relationship of reproduction experience to cancer of the ovary. Am J Epidemiol 1974;99:190-209.
15. Newhouse ML, Pearson RM, Fullerton JM, et al. A case control study of carcinoma of the ovary. Br J Prev Soc Med 1977;31:148-53.
16. Beral V, Fraser P, Chilvers C. Does pregnancy protect against ovarian cancer? Lancet 1978; 1:1083-7.
17. Demopoulos RI, Seltzer V, Dubin N, et al. The association of parity and marital status with the development of ovarian carcinoma: clinical implications. Obstet Gynecol 1979;54:150-5.
18. McGowan L, Parent L, Lednar W, et al. The woman at risk for developing ovarian cancer. Gynecol Oncol 1979;7:325-44.
19. Hildreth NG, Kelsey JL, LiVolsi VA, et al. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol 1981;114:398-405.
20. Franceschi S, La Vecchia C, Helmrich SP, et al. Risk factors for epithelial ovarian cancer in Italy. Am J Epidemiol 1982;115:714-9.
21. Lau H-U, Petschelt E, Poehls, H, et al. Zur Epidemiologie des Ovarialkarzinoms. Arch Geschwulstforsch 1977;47:57-66.
22. Annegers JF, Strom H, Decker DG, et al. Ovarian cancer: incidence and case-control study. Cancer 1979;43:723-9.
23. Willett WC, Bain C, Hennekens CH, et al. Oral contraceptives and risk of ovarian cancer. Cancer 1981;48:1684-7.
24. Wynder EL, Dodo H, Barber HRK. Epidemiology of cancer of the ovary. Cancer 1969;23: 352-70.
25. Rosenberg L, Shapiro S, Slone D, et al. Epithelial ovarian cancer and combination oral contraceptives. JAMA 1982;247:3210-2.
26. West RO. Epidemiologic study of malignancies of the ovaries. Cancer 1966;19:1001-7.
27. McGowan L, Davis RH. Intrasplenic ovarian grafts in Syrian hamsters and peritoneal fluid cellular distribution. Proc Soc Exp Biol Med 1970;134:507-9.
28. Lauritzen C. On endocrine effects of oral contraceptives. Acta Endocrinol (Suppl) 1967; 124:87-100.
29. Cooke ID, Anderton KJ, Lenton E. Hormone patterns at the climacteric. Postgr Med J 1976;52(Suppl 6): 12-6.
30. Larsson-Cohn U, Johansson EDB, Kagedal B, et al. Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy. Br J Obstet Gynecol 1977;85:367-72.
31. Stadel BV. Dietary iodine and risk of breast, endometrial, and ovarian cancer. Lancet 1976;1:890-1.
32. Hoover R, Gray LA, Fraumeni JF. Stilboestrol (diethylstilbestrol) and the risk of ovarian cancer. Lancet 1977;2:533-4.
33. Murphy ED. Major experimental models of ovarian tumors: histogenesis and evaluation. In: Murphy ED, Beamer WG, eds. Biology of ovarian neoplasia. Geneva: UICC, 1980:66-73.
34. Longo DL, Young RC. Cosmetic talc and ovarian cancer. Lancet 1979;2:349-51.
35. Egli GE, Newton M. The transport of carbon particles in the human female reproductive tract. Fertil Steril 1961;12:151-5.
36. deBoer CH. Transport of particulate matter through the human female genital tract. J Reprod Fert 1972;28:295-7.
37. Woodruff JD. The pathogenesis of ovarian neoplasia. Johns Hopkins Med J 1979;144:117-20.
38. Graham J, Graham R. Ovarian cancer and asbestos. Environ Res 1967;1:115-28.
39. Pott F, Friedrichs KH. Tumoren der Ratte nach i.p.-Injektion faserformiger Staube. Naturwissenschaften 1972;59:318.
40. Alden RH. The periovarial sac in the albino rat. Anat Rec 1942;83:421-33.
41. Harrison RJ. The structure of the ovary— mammals. In: Zuckerman S, Mandl AM, Eckstein P, eds. The ovary. New York: Academic Press, 1962:143-87.
42. Rohl AN, Langer AM, Selikoff IJ, et al. Consumer talcums and powders: mineral and chemical characterization. J Toxicol Environ Health 1976;2:255-84.
43. Dixon JR, Lowe DB, Richards DE, et al. The role of trace metals in chemical carcinogenesis: asbestos cancers. Cancer Res 1970;30:1068-74.
44. Thomson R, Webster I, Kilroe-Smith TA. The metabolism of benzo(a)pyrene in rat liver microsomes: the effect of asbestos-associated metal ions and pH. Environ Res 1974;7:149-57.
45. Yaker A, Benirschke K. A ten year study of ovarian tumors. Virchows Arch [Pathol Anat] 1975;366:275-86.
46. Henderson WJ, Joslin CAF, Turnbull AC, et al. Talc and carcinoma of the ovary and cervix. J Obstet Gynecol Br Common 1971;78:266-72.
47. Henderson WJ, Hamilton TC, Griffiths K. Talc in normal and malignant ovarian tissue. Lancet 1979;1:499.